InChIKey	NYMGNSNKLVNMIA-UHFFFAOYSA-N
Canonical SMILES	CC(C)NNC(=O)c1ccncc1
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	2
Pfam Stratification	Homologous
Avg pChEMBL	6.04
Source	ChEMBL;BindingDB

DrugBank ID	DB04818
Drug Name	Iproniazid
CAS Number	54-92-2
Groups	approved withdrawn
ATC Codes	N06AF05
Description	Withdrawn from the Canadian market in July 1964 due to interactions with food products containing tyrosine.

---

Categories: Agents that produce hypertension Agents that reduce seizure threshold Antidepressive Agents Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP2C9 Inhibitors Cytochrome P-450 CYP2C9 Inhibitors (moderate) Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) Cytochrome P-450 Enzyme Inhibitors Enzyme Inhibitors Hydrazines Isonicotinic Acids Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates Monoamine Oxidase Inhibitors Monoamine Oxidase Inhibitors, Non-Selective Nervous System Psychoanaleptics Psychotropic Drugs Pyridines Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome

---

Cross-references: BindingDB: 29136 ChEBI: 5958 CHEMBL92401 ChemSpider: 3617 C11777 D02579 PubChem:3748 PubChem:46505059 RxCUI: 5981 Wikipedia: Iproniazid ZINC: ZINC000000001579